News
-
-
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: Pentixapharm Holding AG completes rights offering and private placement with significant oversubscription generating gross proceeds of approx. EUR 20.4 Million already today
Pentixapharm Holding AG completes rights offering and private placement, raising EUR 20.4 million for PANDA Phase 3 trial, US market expansion, and CXCR4-based theranostic platform development -
-
-
-
-
-
-